Navigation Links
avVaa World Health Care Products Inc. Announces DRTV Test Television Stations
Date:10/2/2009

LUMBY, BC, Oct. 2 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the stations that will feature their Neuroskin(R) Psoriasis Relief DRTV commercial during the two week media test.

avVaa World Health Care Products Inc. is launching a two week DRTV media test run for Neuroskin(R) Psoriasis Relief beginning the week of October 5, 2009. Over one hundred 120, 60, and 30 second commercials will be run during the two week period. The following stations will host a total of 102 scheduled commercials:

    Bloomberg - 3
    Chiller - 5
    CLTV - 16
    Gameshow - 2
    History International - 6
    Military Channel - 7
    New England Cable News - 15
    Ovation - 20
    Sleuth - 7
    Tennis - 11
    THIS TV - 4
    Universal Sports - 6

avVaa's media buyer has also negotiated a number of free 60 second commercials on the same stations. These free commercials are not scheduled in advance, but are expected to total an additional 30 to 40 commercials over the two week period. This will expand avVaa's Neuroskin Psoriasis Relief DRTV test run by about 20% at no additional charge.

The channels chosen for the media test have a subscriber base of 380 million households. National channels were chosen for their large subscriber base and preferred demographic. Regional channels chosen can offer the commercials at a higher frequency. The majority of the commercials will be shown in the daytime.

avVaa President and Chief Operating Officer Lorie Campbell-Farley confirmed that all support systems are ready for the media test. "Our credit card processing, call center and website are all up and running smoothly. Our distribution company has nearly 17,000 bottles of Neuroskin Psoriasis Relief on site. We're set to take off running."

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

CONTACT: avVaa World Health Care Products, Jack Farley, Chairman/CEO, jfarley@avvaa.com; Lorie Campbell-Farley, President/COO, lcfarley@avvaa.com; Investor Relations: Merle Goertz (West Coast), (604) 688-2349

SOURCE avVaa World Health Care Products


'/>"/>
SOURCE avVaa World Health Care Products
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
2. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
3. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
4. avVaa World Health Care Products, Inc. Announces the completion of its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief
5. avVaa World Health Care Products Inc. Announces Second DRTV Test Week
6. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
7. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
8. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
9. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
10. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
11. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... 27, 2017  Kinexum, a distinguished resource for research, ... the appointment of Thomas C. Seoh as ... M.D., Kinexum founder, who becomes Executive Chairman and will ... clients. Thomas Seoh commented, "I ... mission and lead the firm,s remarkable team of life ...
(Date:4/26/2017)... ... April 25, 2017 , ... LABS, Inc. (LABS) announced in December ... its extensive test menu: Nucleic Acid Testing (NAT) for ZIKV; and Enzyme Immunoassays (EIAs) ... to offer NAT screening for blood donors under an Investigational New Drug (IND) study ...
(Date:4/26/2017)... , April 26, 2017  Genisphere LLC, ... platform, has signed a collaborative and sponsored research ... Silvia Muro . The overall goal of ... pharmacodynamics of various 3DNA designs and formulations after ... targeting diseases of the vasculature as well as ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
Breaking Biology Technology:
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/30/2017)... 2017  On April 6-7, 2017, Sequencing.com will host ... hackathon at Microsoft,s headquarters in Redmond, ... on developing health and wellness apps that provide a ... Genome is the first hackathon for personal genomics ... companies in the genomics, tech and health industries are ...
Breaking Biology News(10 mins):